We Improve the Discoverability of Press Releases
NewsRamp™ is the PR and Newswire technology platform that transforms press releases into AI-optimized and multi-modal unique content formats designed to maximize discovery, engagement and global reach. NewsRamp™ primarily services newswires and news publishers.
Latest News
Carotid Artery Procedures Don't Boost Brain Function, Study Finds
about 3 hours ago

LIXTE Biotech Targets Cancer Resistance to Boost Existing Therapies
about 5 hours ago

Benzinga Webinar: Turn Market Volatility into Income with Options
about 5 hours ago

Canamera Resumes Brazil Rare Earth Drilling After Rain Delay
about 6 hours ago

HR News
HR Study: Talent Acquisition Crisis Costs Firms Billions, AI Offers Hope
about 5 hours ago
OrangeHRM 8.0 Launches with Citra AI to Transform HR into Culture Architects
about 13 hours ago
HR.com Partners with VirgilHR to Revolutionize HR Compliance Technology
2 days ago
AI Hiring Bias Exposed: New 2026 Laws Protect Job Seekers from Algorithmic Discrimination
3 days ago
Emplify Health Earns Gold Family-Friendly Workplace Certification
4 days ago
Business News
OS Therapies' Osteosarcoma Treatment Advances Toward FDA Approval
in 8 months
OS Therapies Advances Breakthrough Osteosarcoma Treatment Toward Approval
in 8 months
Cingulate's ADHD Drug CTx-1301 Advances Toward 2026 FDA Decision
in 4 months
GridAI Appoints Energy Tech Veteran Tim Healy as Executive Chairman
30 minutes ago
DRCR Transforms into Waste Oil Recycler While Spinning Off Tech Business for IPO
about 4 hours ago
Crypto News
Datavault AI to Distribute Dream Bowl Meme Coin II to Shareholders
about 1 hour ago
Datavault AI to Distribute Dream Bowl Meme Coin II to Shareholders
about 7 hours ago
DitGold's DITAU Token to Launch on Biconomy Exchange in 2026
1 day ago
Perpetuals.com AI Filters 92% of Losing Crypto Trades in Breakthrough Pilot
1 day ago
White House Seeks Crypto-Banking Compromise to Revive Stalled Legislation
1 day ago
Health News
OS Therapies' Osteosarcoma Treatment Advances Toward FDA Approval
in 8 months
OS Therapies Advances Breakthrough Osteosarcoma Treatment Toward Approval
in 8 months
Cingulate's ADHD Drug CTx-1301 Advances Toward 2026 FDA Decision
in 4 months
Carotid Artery Procedures Don't Boost Brain Function, Study Finds
about 3 hours ago
Dual Therapy Boosts Stroke Recovery: Clot Removal Plus Medication Shows Promise
about 3 hours ago
Technology News
GridAI Appoints Energy Tech Veteran Tim Healy as Executive Chairman
30 minutes ago
Finoveo's White-Label PFScores Helps Banks Boost Growth Through Financial Wellness
about 5 hours ago
TechForce Robotics Scales AI Service Robots to Solve Labor Shortage Crisis
about 5 hours ago
Better Buildings for Humans Podcast Launches Season 3 with Top Architects
about 6 hours ago
GridAI Tackles AI's Power Bottleneck with Energy Orchestration Tech
about 6 hours ago
Events & Conferences
Carotid Artery Procedures Don't Boost Brain Function, Study Finds
about 3 hours ago
Dual Therapy Boosts Stroke Recovery: Clot Removal Plus Medication Shows Promise
about 3 hours ago
Benzinga Webinar: Turn Market Volatility into Income with Options
about 5 hours ago
Top Stroke Scientists Honored at International Conference 2026
1 day ago
MASL Launches 'Play with Heart' to Teach Lifesaving CPR During Games
1 day ago






